E-ISSN 2148-5607
RELATED ARTICLES
Editorial
Effects of Giardia lamblia infestation on the clinical sourse of cronic hepatitis B
(Turk J Gastroenterol 1998; 9: 24-27)
Acral erythema induced bu interferon alpha in a child
(Turk J Gastroenterol 1998; 9: 70-72)
Diagnostic value of serum copper, zinc and plasma fibrinogen in cirrhotic patients with and without hepatocellular carcinoma
(Turk J Gastroenterol 1998; 9: 108-112)
Apoptosis in selected liver diseases
(Turk J Gastroenterol 2009; 20: 171-179)
DOI: 10.4318/tjg.2009.0003
The prevalence of hepatocellular carcinoma in patients with liver cirrhosis in Southeastern Turkey
(Turk J Gastroenterol 1998; 9: 217-220)
The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: An analysis of clinical studies
(Turk J Gastroenterol 2006; 17: 25-34)
An asymptomatic huge hepatocellular carcinoma with intra-atrial tumor thrombus in a patient with chronic hepatitis B viral infection
(Turk J Gastroenterol 2006; 17: 203-205)
Assessment of bone metabolism and mineral density in chronic viral hepatitis
(Turk J Gastroenterol 2006; 17: 260-266)
Immunomodulatory effects of HBsAg vaccine and levamisole in chronic hepatitis B and hepatitis B carrier children
(Turk J Gastroenterol 2005; 16: 188-193)
E-cadherin expression in hepatitis B virus related hepatocelluler carcinoma: Comparison of normal, chronic hepatitis and cirrhotic liver
(Turk J Gastroenterol 1999; 10: 92-94)
Effect of interferon treatment on glucose metabolism in children with chronic hepatitis B infection
(Turk J Gastroenterol 2004; 15: 4-10)
Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha
(Turk J Gastroenterol 2004; 15: 213-218)
Predictive value of proliferating cell nuclear antigen index in response to interferon treatment in patients with chronic viral hepatitis B and C
(Turk J Gastroenterol 2001; 12: 89-94)
The effect of recombinant hepatitis B vaccine therapy in chronic hepatitis B infection
(Turk J Gastroenterol 2002; 13: 6-10)
The value of fine needle aspiration biopsy in the diagnosis of metastatic liver tumours
(Turk J Gastroenterol 2002; 13: 78-82)
Diagnostic value of color doppler ultrasonography in hepatocellular carcinoma
(Turk J Gastroenterol 1996; 7: 298-302)
Clinicopathologic features and risk factors for hepatocellular carcinoma: Results from a single center in southern Turkey
(Turk J Gastroenterol 2003; 14: 85-90)
Two cases with hepatocellular carcinoma and spleen metastasis
(Turk J Gastroenterol 2003; 14: 138-140)
Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: Clinical significance and correlation with serological markers
(Turk J Gastroenterol 2003; 14: 157-163)
The use of tissue polypeptide specific antigen as a marker in liver diseases
(Turk J Gastroenterol 2003; 14: 177-180)
Clear cell carcinoma of the liver: A case report
(Turk J Gastroenterol 2003; 14: 211-214)
A comparative immunohistochemical study of HBsAg, HBcAg and CD57 in chronic hepatitis B pediatric patients with and without malignant disorders
(Turk J Gastroenterol 2003; 14: 234-238)
An analysis of our with hepatocellular carcinoma
(Turk J Gastroenterol 1997; 8: 36-40)
Evaluation of the outcome of interferon therapy in chronic hepatitis B infection
(Turk J Gastroenterol 1999; 10: -)
Determination of intracellular Th1/Th2 type cytokines in lymphocytes of chronic hepatitis B patients treated with interferon-alpha
(Turk J Gastroenterol 2010; 21: 401-410)
DOI: 10.4318/tjg.2010.0127
Relationship between serum levels of interleukin-10, interleukin-2 and soluble intercellular adhesion molecule-I and liver injury in chronic hepatitis B virus infection
(Turk J Gastroenterol 1999; 10: 243-248)
Review
Emerging therapeutics and relevant targets for chronic Hepatitis B
(Turk J Gastroenterol 2016; 27: 210-215)
DOI: 10.5152/tjg.2016.15521
Case Report
A case of entecavir resistance which is developed after complete viral suppression during entecavir treatment for nucleoside-naive chronic hepatitis B
(Turk J Gastroenterol 2014; 25: 206-209)
DOI: 10.5152/tjg.2014.3605
A case of gynecomastia due to entecavir
(Turk J Gastroenterol 2010; 21: 313-316)
DOI: 10.4318/tjg.2010.0108
Synchronous occurrence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in both lobes of the liver
(Turk J Gastroenterol 2014; 25: 209-211)
DOI: 10.5152/tjg.2014.6188
Hepatocellular carcinoma presenting as a huge intra-abdominal mass: A case report
(Turk J Gastroenterol 2014; 25: 330-332)
DOI: 10.5152/tjg.2014.3255
Original Article
Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysis
(Turk J Gastroenterol 2014; 25: 147-152)
DOI: 10.5152/tjg.2014.4888
MR imaging in diffuse-type hepatocellular carcinoma with synchronous portal vein thrombi
(Turk J Gastroenterol 2011; 22: 158-164)
DOI: 10.4318/tjg.2011.0185
Transarterial chemoembolization for treatment of hepatocellular carcinoma: A single center experience
(Turk J Gastroenterol 2013; 24: 141-147)
DOI: 10.4318/tjg.2013.0709
AST-platelet ratio index in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis B
(Turk J Gastroenterol 2012; 23: 353-358)
DOI: 10.4318/tjg.2012.0348
Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t)ide-naive patients with chronic hepatitis B
(Turk J Gastroenterol 2012; 23: 247-252)
DOI: 10.4318/tjg.2012.0380
18F-FDG PET CT as a prognostic factor in hepatocellular carcinoma
(Turk J Gastroenterol 2015; 26: 344-350)
DOI: 10.5152/tjg.2015.0152
Gallstones in liver transplant recipients: A single-center study in China
(Turk J Gastroenterol 2015; 26: 429-434)
DOI: 10.5152/tjg.2014.6344
Evaluation of local tumor residue after percutaneous radiofrequency ablation therapy for hepatocellular carcinoma
(Turk J Gastroenterol 2017; 28: 197-201)
DOI: 10.5152/tjg.2017.16641
Combination of DKK1 and AFP improves diagnostic accuracy of hepatocellular carcinoma compared with either marker alone
(Turk J Gastroenterol 2016; 27: 375-381)
DOI: 10.5152/tjg.2016.15523
Liver - Original Article
Percutaneous microwave ablation for HCV-related hepatocellular carcinoma: Efficacy, safety, and survival
(Turk J Gastroenterol 2019; 30: 445-453)
DOI: 10.5152/tjg.2019.17191
Assessing the characteristics and feasibility of preventing early mortality in patients with hepatocellular carcinoma
(Turk J Gastroenterol 2019; 30: 541-548)
DOI: 10.5152/tjg.2019.18654
Contrast-enhanced ultrasound-guided radiofrequency ablation in inconspicuous hepatocellular carcinoma on B-mode ultrasound
(Turk J Gastroenterol 2017; 28: 446-452)
DOI: 10.5152/tjg.2017.17104
Regular hospital visits improve the prognosis of hepatocellular carcinoma after initial diagnosis: A single regional community hospital study
(Turk J Gastroenterol 2017; 28: 353-360)
DOI: 10.5152/tjg.2017.17163
Basic & Translational - Original Article
An in vivo RNAi mini-screen in Drosophila cancer models reveals novel potential Wnt targets in liver cancer
(Turk J Gastroenterol 2019; 30: 198-207)
DOI: 10.5152/tjg.2018.18241
Claudin-9 enhances the metastatic potential of hepatocytes via Tyk2/Stat3 signaling
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2019.18513
Oral Presentation
Effects of small molecule inhibitors on liver cancer stem cells in comparison with Sorafenib
(Turk J Gastroenterol 2019; 30: 7-7)
DOI: 10.5152/tjg.2019.05
Poster
Nonsirotic chronic hepatitis B presenting with hepatocellular carcinoma: a case report
(Turk J Gastroenterol 2019; 30: 16-17)
DOI: 10.5152/tjg.2019.08
From cirrhosis to hepatocellular carcinoma: An investigation into hepatitis C viral oncogenesis using meta-analysis
(Turk J Gastroenterol 2019; 30: 26-28)
DOI: 10.5152/tjg.2019.15
Efficacy of entecavir treatment for up to 5 years in patients with HBV-related compensated cirrhosis in Turkey; real life data
(Turk J Gastroenterol 2019; 30: 36-36)
DOI: 10.5152/tjg.2019.22
Evaluation of 24-year followig results of patients with inactive hepatitis B
(Turk J Gastroenterol 2019; 30: 55-55)
DOI: 10.5152/tjg.2019.35
Diagnostic value of computerized tomography ın differential diagnosis of liver nodules
(Turk J Gastroenterol 2019; 30: 64-64)
DOI: 10.5152/tjg.2019.41
A case with chronic HBV infection who was non-responder to nucleos(t)ide analogues was treated with Pegylated interferon
(Turk J Gastroenterol 2019; 30: 70-72)
DOI: 10.5152/tjg.2019.47
Clinical and laboratory features of children with chronic hepatitis B infection: A single center results
(Turk J Gastroenterol 2019; 30: 74-74)
DOI: 10.5152/tjg.2019.49
Clinical outcomes after cessation of potent antiviral treatment in chronic hepatitis B patients
(Turk J Gastroenterol 2019; 30: 81-82)
DOI: 10.5152/tjg.2019.54
Poster Presentation
The evaluation of liver biopsy specimens of chronic hepatitis B patients using early tissue markers for Hepatocellular Carcinoma: Before and after the development of Hepatocellular Carcinoma
(Turk J Gastroenterol 2019; 30: 102-102)
DOI: 10.5152/tjg.2019.67
Key Words
Authors
All
Reviewer's Corner
Author’s Corner
Survey
AVES | Copyright © 2019 Turkish Society of Gastroenterology | Latest Update: 04.07.2019